Century Therapeutics, Inc

Century Therapeutics is a biotechnology company focused on developing innovative cell therapies for cancer and autoimmune diseases. Their approach utilizes induced pluripotent stem cells (iPSCs) to generate allogeneic NK and T cells, which are engineered to be more effective and tolerable than existing cell therapies. This proprietary platform integrates cutting-edge gene editing, protein engineering, technical development, and manufacturing capabilities to create therapies that can be dosed as needed until patients achieve a durable response.

Century is committed to expanding patient access to life-saving therapies by developing products that are more accessible and affordable. They are led by pioneers and industry veterans with decades of experience in bringing cell therapy products to market, supported by a Scientific Advisory Board of world-renowned scientists and clinicians. They are currently conducting multiple clinical trials, including a Phase 1 trial evaluating CNTY-101 in patients with systemic lupus erythematosus and lupus nephritis, and another Phase 1 trial assessing CNTY-101 in patients with relapsed or refractory CD19-positive B-cell lymphomas.

Century Therapeutics offers a comprehensive benefits package designed to support employees' well-being and financial security. They provide comprehensive health coverage including medical, dental, and vision, along with flexible spending and health savings accounts. Employees also receive a 401(k) retirement plan with employer contributions, life and disability insurance, and an employee assistance program for personal support. They offer generous paid time off, including regular PTO, wellness days, and volunteer days, as well as a colleague recognition program and cellphone reimbursement. The company also offers parental leave to support working families.

Century Therapeutics is an innovative biotechnology company committed to expanding patient access to life-saving cell therapies. Their mission is to develop allogeneic, iPSC-derived NK and T cell therapies for cancer and autoimmune diseases. They are driven to create innovative products that are more effective, tolerable, accessible, and affordable than existing cell therapies. Century Therapeutics is dedicated to engineering an evolution in immunotherapy, ultimately transforming the treatment landscape for patients battling these diseases.

Century Therapeutics fosters a collaborative and inclusive culture that prioritizes innovation and scientific rigor. The company values integrity, passion, and courage in its pursuit of developing life-saving cell therapies. Century encourages a diverse workforce, where different perspectives are valued, and challenges the status quo to push the boundaries of cell therapy research. The company also emphasizes work-life balance and employee well-being, creating a supportive environment where team members feel valued and can achieve their full potential.

Century Therapeutics recognizes the strength in diversity and actively works to create an inclusive workplace that values different backgrounds, perspectives, and experiences. They believe in breaking down unconscious bias, raising awareness of important issues, and ensuring their actions extend beyond their company walls into the communities they serve. Century strives to foster an environment where all races, genders, ethnicities, and perspectives have a place within the Century Family.